Stocks in Focus on Mar 9: Sun Pharma, TCS, NMDC & More

  • Investing.com
  • Stock Market News
Stocks in Focus on Mar 9: Sun Pharma, TCS, NMDC & More
Credit: © Reuters.

By Malvika Gurung

Investing.com -- Sun Pharmaceuticals (NS: SUN ): The drugmaker subsidiary Taro Pharmaceuticals USA has acquired the subsidiary companies of the Swiss pharma company Galderma, paying $99.279 million for the complete transaction.

Tata Consultancy Services (NS: TCS ): The IT giant’s share buyback of Rs 18,000 crore will open on Wednesday and close on Mar 23, with plans to buy back 4 crore shares at Rs 4,500 apiece.

Titan Company (NS: TITN ): The company is in advanced talks with the wearables maker Noise, to acquire a majority stake in it, as it aims to strengthen its hold in the wearables industry.

Bharat Forge (NS: BFRG ): The auto ancillary company’s subsidiary Kalyani Strategic Systems has entered into a JV with Dastan Transnational to form Sagar-Manas Technologies for providing services to marine and defence products.

IndiGo (NS: INGL ), Spicejet (BO: SPJT ): The Indian government has announced resuming commercial international passenger services to and from India, starting March 27.

NMDC (NS: NMDC ): The largest iron ore miner in the country has raised the prices of lump ore and fines by Rs 400/ton with immediate effect, revising the prices for the second time in two weeks.

Zydus Lifesciences (NS: ZYDU ): The pharmaceutical company’s subsidiary Sentynl Therapeutics will acquire a brand from the US-based BridgeBio Pharma, stated news reports.

Yasho Industries (BO: YASO ): The chemicals company’s board will consider capex for a new greenfield project on Mar 16, which will have a capacity of 15,500 metric tons p.a. in Gujarat’s Bharuch.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles